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1. INTRODUCTION
It is a great privilege to give this, the third
Herman Beerman Lecture, on "Transplantation:
Past, Present and Future" in honor of a man to
whom biologists and clinicians alike owe a great
debt for his invaluable services to the cause of
both experimental and investigative dermatology.
Probably no branch of medico-biological
science has enjoyed such an explosive growth in
practice and popularity, since the end of World
War II, as that concerned with the transplanta-
tion of biological material at all anatomical levels
of organization. The grafts may be single, dis-
crete cells, such as tumor cells or fertilized ova;
suspensions of cells such as blood or peritoneal
exudates; solid tissues such as shin; completely
functional organs such as ovaries, kidneys, lungs,
or the liver; or, in the extreme case, entire in-
dividuaLs—f or surgical parabiosis involves graf t-
ing the body of one individual onto that of
another (1, 2). Even non-viable grafts of some
tissues, such as preserved bone and cartilage, are
now fairly widely employed in replacement sur-
gery (3, 4).
Every medical school now seems to feel some
obligation to have a "transplantation unit" if
for no other reason than prestige. No conference
on immunology is considered well oriented unless
it includes at least one session on some aspect of
transplantation immunity. Meetings specifically
devoted to the subject, at both the national and
international levels, have become so frequent as
to cause concern whether they aren't now im-
peding progress, rather than facilitating it, by
keeping investigators away from their labora-
tories, traveling or rewriting unnecessarily to
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provide manuscripts for conference impressarios.
Even the daily newspapers and popular maga-
zines, not to mention pharmaceutical house
"Bulletins", reflect the grossly over-emphasized
current popularity and competitive nature of the
wide field now encompassed by the term "tissue
transplantation".
This lecture represents an attempt to outline
the origins, scope, and some of the achievements
and possibilities of transplantation technics and
to analyse, if possible, the basis of its current
popularity.
Although the point is rarely stressed, there is
a very special relationship between "tissue trans-
planters" and dermatologists. Not only does every
act of transplantation necessarily involve damag-
ing skin but, more important and for obvious
reasons, skin is the tissue of choice for grafting
purposes when the type of tissue to be trans-
planted is not a parameter of the experiment.
Although close affinity between dermatology
and surgery is admitted by neither profession,
it is interesting that Sir Erasmus Wilson, Presi-
dent of the Royal College of Surgeons of England
in 1881, is now recognized as having been an
outstanding English dermatologist. According
to an anonymous biographer (5) "to his teaching
we owe in great measure the use of the bath,
which has since become a conspicuous feature
in the life of our upper and middle classes".
Apparently at the suggestion of Thomas Wakley,
then editor of the Lancet, who advised him to
"link himself so closely with skins that when he
entered a room the company would scratch
themselves", Wilson apparently foresook a suc-
cessful career in anatomy and surgery in favor of
dermatology.
2. HISTORICAL ORIGINS
a) Skin Transplantation
It's quite certain that man was the first victim,
or beneficiary, of tissue transplantation. Long
before the birth of Christ, Hindu surgeons of the
Tilemaker caste had evolved a technic for re-
constructing an amputated nose by transposition
of flaps of skin from the patient's forehead. There
are grounds for believing that they could also em-
ploy free skin grafts for this purpose (6).
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The first fully documented experimental trans-
plantation of free, full-thickness autografts of
skin was carried out in a sheep, by a Milanese
physiologist, Baronio (7), in 1804. He noted that
hair was regenerated by these grafts and also made
the important observation that separation of the
tissue from the animal for an hour did not per-
ceptibly prejudice its viability, thus hinting at the
feasibility of tissue storage. Eighteen years later,
in 1822, Bunger (8) of Marburg reported the suc-
cessful employment of a free skin graft from a
patient's thigh to reconstruct her nose.
It was Reverdin's (9) classic paper delivered in
1869, describing the use of tiny free skin auto-
grafts—usually referred to as "pinch" grafts—to
promote the long-overdue epithelialization of ex-
tensive granulating wounds, which popularized
skin transplantation as a clinical procedure.
A rather unrewarding diversion in the develop-
ment of therapeutic skin grafting occurred at the
latter end of the 19th century when "zoografting"
was practiced fairly extensively (10). This entailed
heterotransplantation, i.e., transplantation of skin
from alien donor species—e.g., from sheep, rabbits,
pigs, and, most popular of all, from frogs,—to
obstinate ulcers, burn lesions, etc. Zoografts seem
to have been used with incredible enthusiasm.
There is at least one detailed account on record
of an attempt, made in 1880, to transplant flaps of
skin from a lamb to a child. Gibson (10), an
authority of the history of zoografting, rightly
questions what these early authors expected to
happen to their grafts and what actually did
happen to them.
Apparently, in these early days of free skin
grafting, even in the case of autografts, no one
really knew, or probably cared, whether the
grafted tissue grew or not so long as complete
epithelialization took place. Some authors, in-
cluding Reverdin himself, actually believed that
the grafts simply promoted a sort of epithelial
"transformation" on the part of the granulation
tissue. No one resorted to histology to settle the
matter on account of a reluctance to compromise
the fruits of their labors by removal of biopsy
specimens. Although we now know that none of
these heterografts could possibly have survived
for more than a day or two at most, the possibility
cannot be entirely discounted that, in some way or
another, they did sometimes facilitate epi-
thelialization. Rather surprisingly, as recently as
1957, the possible benefits of bovine embryonic
skin as a temporary form of biologic dressing still
attracted the attention of some investigators (11,
12).
The early pioneers of human skin transplanta-
tion made no distinction between the behavior of
grafts of a patient's own skin (i.e., autografts)
and those derived from the bodies of other in-
dividuals (i.e., which we call homografts). George
Lawson (13), of London, undoubtedly voiced the
naive opinion of his times when he predicted in
1870 that ". . . . the time will come when we shall
beg portions of skin from a parent or friend who is
willing to give of his abundance for the relief of a
suffering child or of a neighbor". Little did he
realize that in addition to public spirited
generosity, fulfillment of this prediction requires
the solution of a formidable biological obstacle
which is still the central problem of transplanta-
tion research.
Following the popularization of plastic surgery,
about 70 years were required before the widespread
belief that skin from one individual would form a
permanent graft on the body of another received
its long overdue burial. This tenacious adherence
to a fallacy occurred in the face of compelling evi-
dence and declarations to the contrary by some of
the early investigators such as Erich Lexer and
Georg Schöne (see 14, 15).
In an autobiography of 1930, Sir Winston
Churchill (16) narrates how, in 1899, he donated a
skin graft to a brother officer, wounded in battle
against the Dervishes in Egypt. After describing
his sensations as the doctor's razor sawed slowly
to and fro, Churchill says, "I managed to hold out
until he had cut a beautiful piece of skin with a
thin layer of flesh attached to it. This precious
fragment was then grafted onto my friend's
wound." Always an optimist, the Statesman
added, "It remains there to this day and did him
lasting good in many ways".
b) Tumor Transplantation
Studies on the transplantation of malignant
tissues date back to 1889 when Hanau transferred
a rat carcinoma from one rat to other members of
this species. However, the real pioneer in this field
was Jensen who found that spontaneous murine
tumors could sometimes be propagated by trans-
plantation from one mouse to another, and took
pains to satisfy himself that what he was propa-
gating was a lineage of cells and not some sort of in-
fectious agent. In 1902 he reported on a tumor
which he had passed through 19 generations by
grafting and which grew in about 50% of inocu-
lated subjects (15 and 17).
During the first decade of the present century it
was clearly established by Jensen and others that
the "race" of the host mice was important from
the point of view of susceptibility to a tumor graft.
Extensive studies carried out during this period
revealed that transplanted tumors either grew
for a while, attaining palpable dimensions and
then regressed, or sometimes seemed not to grow
at all. Mice in which tumor grafts had regressed,
or had apparently failed to grow at all, proved to
be resistant on subsequent inoculation with the
same tumor and sometimes to other tumors as
well.
Particularly important was the evidence that
successful tumor transplantation could be pre-
vented by prior treatment of the host with grafts
of normal tissues, such as those derived from em-
bryos, or blood.
The important principles that gained recogni-
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TABLE 1
Some landmarks in the history of transplantation research, up to 1946
Time Investigators Event
B.C. Hindu Surgeons Utilized flap-grafts of forehead skin, and possibly free skin grafts,
to repair amputated noses. (see 6)
1503 Branca, Sicilian Tried to employ slave's skin to reconstruct his master's nose.
surgeon (see 6)
1665 Richard Lower, Successfully cross-transfused blood between two dogs. (see 89)
London
1771 John Hunter, Transplanted gonads in chickens and spur of cock to its comb.
London (see 79)
1804 Baronio, Italy Successfully transplanted full-thickness skin autografts in a sheep.
(7)
1822 Bunger, Marburg Reconstructed a lady's nose by means of free skin autograft of thigh
skin. (8)
1849 Berthold Transplanted testes in cockerels and established their endocrine
function. (see 79)
1869 Reverdin, Paris Popularized use of small skin autografts ("pinch" grafts) to procure
epithelialization of granulating wounds. (9)
1872 Ollier Employed large, "thin, split-thickness" skin grafts. (see 6)
1873 Aveling Carried out successful cross-transfusions of blood in man. (see 89)
1875 Wolf Introduced use of "full-thickness" skin grafts. (see 6)
1886 Thiersch Independently advocated use of large, split-thickness skin grafts.
(see 6)
1888 Von Hippel Performed first successful corneal graft in man. (see 2)
1889 Hanau Successfully transferred a carcinoma between rats. (see 17)
1902 Jensen Succeeded in passaging a murine tumor through 19 generations of
grafting. (see 15, 17)
1905 Carrell & Cuthrie Successfully autotransplanted kidneys in dogs. (see 2, 78)
1908 Georg Schone Recognized that tumor homografts regressed because cells are alien
to the body.
Proposed the term "Transplantations-immunitat". (21)
1911 Ehrich Lexer Declared that skin homografts are invariably unsuccessful. (see
14, 15)
1909—16 Little & Tyzzer Established genetic basis of tissue transplantation. (see 23)
1937—38 Corer Demonstrated that humoral isoantibodies are formed in response
to homografts of tumor tissue in mice.
Postulated identity of histocompatibility genes with genetic de-
terminants of isoantigenic differences. (23)
1943—45 Medawar Established that rejection of homografts of normal tissue—skin—
is an immunological phenomenon. (15, 20)
1939—46 Popularization of blood transfusion as a routine therapeutic pro-
World War cedure. (see 89)
II
tion from this tremendous output of work, carried unwittingly using tumors, in not always the most
out under the banner of cancer research, were that effective manner, to study transplantation (15).
tumor graft regression, and the prevention of
tumor graft acceptance by prior treatment with As Woglom (18) put it "the tumor problem.living cells—normal or malignant—was an im- . .
munological phenomenon—the immunity involved was a tissue problem, resistance being directed
being directed against tissue foreign to the body, against the tumor graft as a sfrange tissue merely,
whether it was of normal or malignant origin, and not connected with any neoplastie qualities
there being no qualitative differences. Nearly all .
the early workers who believed that they were which the graft happened to possess
using transplantation to study cancer were in fact Only recently and by means of specially sen-
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sitive teçhnics has the existence of a group of
tumors, inducible with certain chemical or viral
agents, been established where antigenic differ-
ences are demonstrable between primary hosts
and their tumors (19).
Until the early 1940's practically all the basic
information on the incompatibility of homografts
came from studies carried out with tumors, prin-
cipally because of the case with which they could
be transplanted.
In a series of classic papers published between
1943 and 1945, Medawar (15, 20) established
unequivocally, for the first time, that the reac-
tion provoked by homografts of normal tissue—
skin—is an actively acquired immunity. These
studies focused attention upon many incompa-
rable advantages of skin over all other tissues—
normal or malignant—for quantitative studies
on the homograft reaction.
Thus studies on grafts of normal and malig-
nant tissues have had separate origins and his-
tories, and not until about the mid-1940's was
the time ripe for fruitful exchange of thought and
information on biological problems of trans-
plantation, and especially upon transplantation
immunology, between students of these two types
of grafts. It is interesting to note that the German
equivalent of "transplantation immunity",
Trans plantationsimmunitat, was proposed by
Georg SchOnc (21) in 1908.
3. TRANSPLANTATION IMMUNOLOGY
From the early beginnings of their subject the
principal objectives of transplantation immunolo-
gists were obvious :—1) To elucidate the nature
of the factors responsible for the incompatibility
of homografts; 2) To determine how transplanta-
tion immunity is put into effect; and 3) To try
and devise means of enforcing permanent ac-
ceptance of tissue or organ homografts upon
individuals that would normally reject them, or of
selecting compatible, or relatively compatible
donors, thus paving the way for the practical
realization of the surgeon's dream—to be able to
utilize "sparc parts" for replacement therapy
without the intervention of immunological forces.
To what extent have these goals now been
realized, and what new and unexpected dis-
coveries have emerged from research directed
towards these ends?
The early evidence of the importance of the
"race" of the host in determining the outcome
of tumor transplantation in mice provided the
clue that homograft incompatibility is genetically
determined. Little's classic investigations on the
genetics of tumor transplantation in the mouse,
followed by those of Gorer and Snell and others,
have brought to light the existence of a battery
of at least 15 multiple allelic systems of histo-
compatibility genes, (analogous to the blood
group factors in man) which are the genetic
determinants of the cellular isoantigenic speci-
ficitics that provoke sensitivity to homografts.
Other workers have extended the validity of these
findings to normal tissues (there is no evidence of
any tissue or organ specificity in transplantation
immunology), and to a few other species, includ-
ing rats, guinea pigs, chickens, hamsters and
platyfish (see 15, 20, 22). On the basis of these
animal experiments, supplemented by the results
of restricted studies on exchanged skin grafts in
man, we can only guess at the complexity of the
genetics of tissue transplantation in the latter
species.
An important pre-requisite for these genetic
studies carried out in animals were different
genetically uniform or isogenic strains. What a
tragedy it is that even today we still find many
investigators in transplantation immunology
either unnecessarily complicating their projects
or, not infrequently, vitiating them entirely, by
failure to employ isogenic strains! Unfortunately,
the largest species of mammal of which such
strains are presently available is the guinea pig.
Despite the awareness of a few early investi-
gators that tumor homograft regression is an
immunological phenomenon, progress in this
young and scarcely recognized branch of ad-
munology was greatly handicapped for several
decades by inability to reveal the formation of
huinoral isoantibodics in response to homografts
or to transfer sensitivity to normal hosts. Another
obstacle was the fact that complete disintegra-
tion of cells invariably resulted in disappearance
of their sensitizing properties (20).
It was the classic work of Gorer, from 1938
onwards, and of other investigators, which es-
tablished that the isoantigens determined by at
least some important histocompatibility genes
in mice and other species provoke the formation
of scrologically detectable antibodies (23, 24).
This furnished further evidence, if any was re-
quired, that homograft reactivity is an
immunological phenomenon. Early hopes that
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these antibodies would prove to be the mediators
of homograft destruction in general have not
been sustained. Only in the case of leukotic
tumors, and certain solid or dissociated cellular
homografts transplanted under special circum-
stances, has convincing evidence been forth-
coming of their susceptibility to these antibodies
in vivo (24). Indeed, it has long been known that
the presence of these antibodies may actually
interfere with the primary sensitization of hosts
confronted with solid tissue homografts—the
basis of the phenomenon of immunological
"enhancement" (25).
The important principle that homograft
sensitivity is transferable by means of living
lymphoid cells, and that the principal seats of
reactivity against solid tissue homografts are
the regional lymph nodes were not discovered
until 1954 by Mitchison (26, see also 20 and 22).
This finding dispelled any tendency to consider
that homograft reactivity might be an im-
munological phenomenon sui generis, for trans-
ferability by living cells of the lymphoid series,
but not by putatively immune serum, is one of
the cardinal characteristics of hypersensitivity
reactions of the "delayed" type, including sen-
sitivities or allergies to drugs, micro-organisms
and autoantigenic constituents of the body.
Further work along numerous lines has greatly
strengthened this concept of the close affinity
of homograft reactivity to delayed allergies (22).
It has recently been shown that small lympho-
cytes circulating in the blood stream are just as
capable of transferring homograft sensitivity
passively (more correctly, adoptively) as regional
node cells (27). This may be said to complete the
chain of circumstantial evidence in favor of the
view that the homograft reaction is put into
effect by the infiltration of a homograft by small
immunologically "activated" lymphocytes pro-
duced predominantly in the regional nodes, in
the case of solid tissue homografts, and trans-
ported by the blood stream.
Although the idea, that the infiltrating mono-
nuclear cells invariably associated with the
rejection process in solid tissue homografts are
in some way responsible for the pathogenic
changes observed, was firmly in the minds of
Da Fano, Loch, Murphy and others at the be-
ginning of the century (15, 17, 18), formal proof
is still awaited, despite the increasingly impres-
sive body of circumstantial evidence in favor of
it. At present it must be conceded that the results
of passive transfer attempts with isotopically
labelled cells, or with lymphoid cells sequestered
in cell-impermeable Millipore chambers are
difficult to reconcile with it (22).
If immunologically "activated" lymphocytes
are the vehicles by means of which homograft
hypersensitivity is put into effect, there is little
to suggest how they damage target cells. Do they
release nonspecific, highly potent pharmacologi-
cally active substances in the vicinity of target
cells, as a consequence of an immunologically
activated trigger mechanism? Do they transport
"cell-bound" cytotoxic antibodies which are only
released close to target cells? One could pose
many rhetorical questions and guesses of this
kind. A new experimental approach may help us
here. This entails intimate exposure of mono-
layers of homologous "target" cells to im-
munologically activated lymphoid cells from
specifically sensitized donors in vitro, in the ab-
sence of specific antibodies and complement.
Under these greatly simplified and clearly de-
finable conditions target cell destruction takes
place (28, 22), engendering the hope that this
line of approach will clarify our present extremely
hazy and grossly inadequate concept of im-
munologically "activated" cells as mediators of
various delayed hypersensitivities.
Elucidation of the biochemical nature of the
substances which express the isoantigenic speci-
ficities determined by histocompatibility genes
is proving to be an extremely tough problem,
principally because of the apparent lability of the
substances involved and the difficulty of devising
means of solubilizing them without impairing
their antigenicity.
In 1956 Brent, Medawar and I (29) succeeded
in sensitizing mice against skin homografts by
means of crude, non-living, cell-free antigenic
extracts of disrupted lymphoid cells and so had
the good fortune to open up what is undoubtedly
one of the most important areas of current re-
search in the immunology of transplantation.
It now appears that the antigenic specificities
are associated with lipoproteins located in the
microsomal fraction of homogenized cells (22).
In what physical form these substances actually
escape from grafted tissues and organs (and
presumably they are also released as a normal
physiologic process from the cells of normal,
intact animals) has yet to be discovered. Besides
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their ability to sensitize animals against homo-
grafts the extracted substances are serologieally
active, facilitating their assay and detection (22).
Of particular importance is the question
whether the antigenic speeifieities determined by
the various allelic series of histoeompatibility
genes are associated with macromolecules of
similar biochemical constitution, or whether
these antigenie configurations are associated
with a biochemically heterogeneous group of
substances. Another question is whether, for a
given determinant, the same "species" of "car-
rier" protein is always involved in cells of differ-
ent types.
4. OVERCOMING THE HOMOGRAFT RESPONSE
It was Ray D. Owen's (30) masterly analysis
and interpretation in 1945 of an "experiment of
Nature" tbat was responsible for the research
that led to the discovery of the principle of
immunological tolerance of tissue homografts.
Owen demonstrated that the majority of dizygotic
cattle twins are red cell ehimeras, almost cer-
tainly as a consequence of a natural pre-natal
ei'cehange of the precursors of hematopoietie
cells, through anastomoses that usually inter-
connect the blood circulations of multiple em-
bryos in this species. Evidently this early ex-
posure to each others' cellular antigens renders
dizygotic twins incapable of reacting against
both the pre-natally exchanged cells, and their
mitotie descendants and derivatives in later life.
In 1951, my colleagues and I (31, 32) obtained
evidence that the tolerance induced by this
prenatal exchange of red cell precursors also
extends to skin grafts exchanged between the
twins in later life. This tolerance is highly specific,
for dizygotie twins will not accept homografts
from any other donors.
With this information as our starting point,
we carried out experiments designed to try and
induce tolerance of skin homografts artificially
in chickens, mice, rats and rabbits by injection
of their embryos with living homologous tissue
cells, and challenging them after they had grown
up with skin homografts having the same iso-
antigenic constitution as the prenatally in-
jected cells. These experiments were successful:
exposure of embryos to foreign tissue cells of a
variety of histological types induced tolerance of
subsequent test skin homografts. These findings
were rapid]y confirmed and extended by other
workers. It was soon found that in many species,
including mice, chickens, rats and dogs, that
tolerance could still be induced by inoculation
soon after birth, and that highly tolerant animals
were cell ehimeras, as a consequence of the per-
sistence of the perinatally inoculated cells or
their descendants (32, 33, 34, 35).
Discovery of the principle of immunological
tolerance, which also applies to non-living anti-
gens of other classes, such as heterologous serum
proteins, and to certain microbial constituents,
opened up an entirely new and exciting field of
immunology dealing with the specific suppression
of the capacity to react to an antigen as a con-
sequence of exposure to it in early life, before
the animal's immunological response machinery
was functionally mature. Existing theories of
the nature of the immunological response had to
be re-examined and revised to take this phenome-
non into consideration (34), and new theories
were propounded (36). Particularly important
among these was Eurnet's Clonal Selection Theory
(37) which has proved to be a powerful stimulant
of both thought and research at a fundamental
level in immunology. All this work and thinking,
I snould like to emphasize, was set in motion by
the findings of experiments involving the trans-
plantation of tissues and cells. At long last tissue
"transplanters" and their principal "cult"—-
transplantation immunology—had won long-
overdue acceptance by orthodox immunologists.
During die course of attempts to induce toler-
ance of hoinografts in very young rodents and
birds, by inoculating them with viable suspen-
sions of homologous cells, an entirely new
phenomenon was encountered—a wasting dis-
ease or syndrome, usually described as "runt"
disease (35, 38). Among the more obvious signs of
this condition, which may be acute or chronic
and of delayed onset, are failure to grow and
develop, splenomegaly, hepatomegaly, hyper-
plasm of lymphoid tissue in general, usually
followed by atrophy of many of the lymph nodes.
Sometimes there may be striking abnormalities
of the skin (38). Extensive studies established
that runt disease, which can be produced at will
with appropriate animal strains (it requires a
high degree of genetic disparity between the
donor and recipient strains) when homologous
lymphoid cells from adult donors are inoculated
into immunologically immature hosts, is im-
munological in origin. It is the outcome of a
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reaction on the part of mature, immunologically
competent cells present in the inoculum, against
the foreign transplantation antigens confronting
them in their new hosts—i.e., it is a 'raft-versus-
host reaction. At present the proximate cause of
death in runt disease in unknown.
Overt runt disease, or some components of
this syndrome, such as splenomegallv or
hepatomegally which can be assayed quantita-
tively, form extremely important research tools
and have been widely employed, especially in
the hands of Dr. Morten Simonsen (39).
Since runt disease only occurs when mature,
immunologically competent cells are inoculated
into genetically appropriate hosts, it provides
the basis of a sensitive test for the presence of
these cells in various donor tissues. The capacity
of both avian and mammalian blood to cause
this syndrome indicated, for the first time, that
blood contains immunologically competent cells.
Studies on thoracic duet cells (almost exclusively
"small" lymphocytes) in rats (38, 40), and on
fractionated chicken blood leukocytes (41) have
shown that the small lymphocyte is the im-
munologically competent eel! present in the
blood. Another finding made with the aid of this
test is that chickens' skin, but not that of mam-
mals, appears to contain a relatively fixed popu-
lation of immunologically competent cells (42).
The initial belief that ability to become tolerant
or immunologically unresponsive on exposure to
antigens is the prerogative of young, relatively
immature animals has proved to be incorrect.
Massive single or repeated inoculations of adult
mice with homologous cells may also induce a
state of unresponsiveness to homografts, closely
resembling immunological tolerance in its prop-
erties (see 22). Parabiosis (an experimental sur-
gical procedure introduced by Sauerbruch and
Heyde (43) in 1908), of genetically dissimilar rat
or mouse partners may also lead to unresponsive-
ness to homografts. In these various procedures,
where donors and recipients, or parabionts,
are widely unrelated in an immunogenetic sense,
the intervention of graft-versus-host reactions,
closely resembling runt disease, entails a high
mortality rate. This can sometimes be avoided,
or minimized by appropriate genetic or other
artifices.
Independent investigations along a different
line, carried out at about the same time as the
basic work on immunological tolerance, led to the
discovery of an alternative "laboratory" solu-
tion to the homograft problem, principally ap-
plicable to mice and rats. This has provided yet
another fruitful new field for transplantation
studies. It turns upon the important observation
that adult animals can be saved from the effects
of otherwise lethal dosages of x-irradiation by
giving them a "transfusion" or cellular homograft
of living hematopoietic cells—prepared from
infant spleen or liver, or from adult bone marrow
(15, 20, 44). These cells rapidly colonize appro-
priate sites in the irradiated hosts, making good
the loss of the cells destroyed. Both isologous and
homologous cellular grafts are effective in this
respect. Homologous radiation chimeras will
accept homografts of skin and other tissues hav-
ing a genetic constitution similar to that of the
"borrowed" hematopoietic cells upon which they
are living.
An untoward complication of the employment
of homologous tissue cells to rehabilitate irradi-
ated animals was soon observed—a wasting
disease sometimes referred to as "secondary
radiation sickness", or "homologous disease".
Analysis of this syndrome has shown that it is
usually another manifestation of a graft-versus-
host reaction, caused in this case by the presence
of immunologically competent cells in the trans-
fused hematopoietic cell inoculum. In certain
circumstances, however, homologous disease
may result from recovery of immunological
function on the part of the host and subsequent
destruction of the borrowed hematopoietie tissue
cells, leading to sickness and death through
deprivation of the services of these important
elements.
Each of the three principal manifestations of
graft-versus-host reactivity we have considered:
—runt disease, parabiosis intoxication, and the
homologous disease of radiation chimeras—
presents interesting problems which have been
intensively investigated. Some investigators have
seen in them useful models of an autoimmune
disease (45) in the sense that, despite their foreign
origin, the cells responsible for mounting the
immunological attack are both anatomically and
functionally part of the host's own. body. There
certainly remains considerable scope for further
studies on the immunopathology of these con-
ditions and for further exploration of possible
means of preventing or curing them (46, 47)
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without negating the desired influence of the
inoculated cellular homografts.
The Clinical Application of Homografts
Stimulated by the results of successful experi-
ments in mice, attempts have been made to
treat leukemia in man by exposure to relatively
high dosages of whole body irradiation, followed
by marrow transfusion from a donor, preferably
an identical twin when available, to make good
the destruction of the host's hematopoietic sys-
tem (44). However, neither the irradiation, nor
the graft-versus-host reaction where homolgous
marrow was employed, have succeeded in eradi-
cating all the malignant cells from the patients,
as evidenced by the recurrence of the disease.
Homologous bone marrow "cellular" homo-
grafts were apparently responsible for the re-
covery of a few victims of radiation accidents,
such as that which took place in a nuclear re-
actor in Yugoslavia in 1959. The grafted cells
and their descendants presumably "tided" the
hosts over until their own hematopoietic tissues
had recovered. No one has yet succeeded in
producing permanent red cell chimerism in man
by marrow transfusion following irradiation or
administration of radiomimetie drugs.
Though not always recognized as such, blood
transfusion undoubtedly constitutes a widely
employed and highly successful "cellular" homo-
grafting procedure. Of course only the erythro-
cytes are important here and the longevity of
these cells after transfusion into compatible
homologous hosts depends upon the fact that
they do not manifest histocompatibility gene
products in a form that sensitizes their hosts.
Furthermore, in man, as in the rabbit, there is
something peculiar about the intravenous route
—it is not an effective route so far as the capacity
of certain types of "cellular" homografts, in-
cluding leukocytes, to sensitize against subse-
quent tissue homografts is concerned (48, 49).
The success attending the use of eorneal homo-
grafts by ophthalmic surgeons almost certainly
turns upon immunologically distinctive features
of the host's cornea as a recipient area. Like the
hamster's cheek pouch and the brain, it is an
immunologically privileged site—i.e., one in
which homografts either fail to elicit a response,
or are exempt from ita consequences, because. of
a break in either the afferent or the efferent
pathways of the immunological reflex (1, 50, 51).
Other types of homograft which are fairly widely
employed, such as bone or cartilage, owe their
success to the fact that continued or even initial
viability on their part is not essential for them
to fulfill a clinically useful role—they simply
provide matrices which are repopulated by host
cells, rather like homologous blood vessel grafts
and their successors, synthetic fiber "tubes"
(2, 4). However, in live cartilage homografts the
cells live in a physiologically protected environ-
ment, invulnerable even to a state of pre-existing
sensitivity (52).
Despite their short life expectancy skin homo-
grafts are still used as a sort of "natural" physio-
logical dressing in cases of extensive full thick-
ness skin loss caused by burning, etc. They may
tide the patient over until definitive repair can be
effected by means of skin autografts (6).
Although there is no reason to doubt that
transplantation of lungs, livers, and probably
even hearts, is now technically feasible in man
(see 2), the emphasis of interest and activity is
principally upon the kidney at present, on ac-
count of the incidence of renal diseases in young
people and the fact that nearly everyone can
dispense with one of these organs without incur-
ring a serious handicap.
Irradiation, and an ever increasing diverse
panel of drugs, including cortisone, 6-mercap-
topurine, methotrexate or amethopterin, and
Actinomysin C, are known to be capable of exert-
ing a more or less nonspecific depressant effect
upon the ability of the immunological response
machinery to react against various types of
antigen, including homografts. Encouraged by the
successes attending renal transplantation between
identical twins on the one hand, and by some
more or less empirically arrived at successes in
prolonging the lives of functional renal homo-
grafts in dogs by means of some of these im-
muno-depressant agents, singly or in combina-
tion, on the other, surgeons are now performing
renal homografts in man at many centers
throughout the world (53, 54, 55). All the find-
ings indicate that this "jumping the gun" has
been attended by much more favorable results
than could have been predicted from studies on
skin homografts in laboratory animals. Indeed,
there are some grounds for belief that it may be
easier to enforce acceptance of renal homografts
than those of skin. There are now several human
beings who have been fortunate enough to have
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lived on "borrowed" donor kidneys for upwards
of a year and, at the time of writing, quite a few
who have had more than 6 months good use out
of their renal homografts.
Here we have the unusual situation of more or
less successful empirical "experiments" being
conducted upon manhimself, in the full knowledge
that resort will have to be made to experimental
animals to rationalize them.
Everyone is fully aware that renal homotrans-
plantation, as a therapeutic procedure, is still in
its infancy and that present diverse measures of
obtaining success are empirical and unpredictable
in their efficacy. However, in the light of ac-
complishments to date, one can no longer enter-
tain any doubts that clinical solution of the organ
homograft problem will soon be attained, con-
ceivably before the skin homograft problem is
solved. However, it must be pointed out that
solution of the homograft problem may not
provide the final answer to renal or other organ
diseases. Extension of the original disease into
the grafted organ is a possibility that must always
be borne in mind.
From the immunological standpoint, there
are good grounds for belief that during drug- or
otherwise-enforced acceptance of a renal homo-
graft upon a host, its own antigenic output,
presumably released directly into the host's blood
stream, may gradually and specifically weaken
his ability to react against it, through the induc-
tion of transplantation tolerance.
Some of Medawar's (56) recent studies on
mice have shown that homologous tissue extracts,
containing transplantation antigens, can be
prepared in such a form that on administration
by an appropriate route (the intravenous is most
effective) they don't excite transplantation
sensitivity but can actually induce a perceptible
degree of tolerance in respect of skin homo-
grafts. More important is his finding that these
agents may act synergistically with certain
immunologic depressant agents to give even
greater degrees of tolerance than arc procured by
either the antigen or the agent on its own. This
opens np the possibility that current procedures
for prolonging renal homograft survival may be
rendered much more effective by concomitant
inoculation of the host with appropriately ad-
ministered extracts of donor cells. Obviously
when antigcnically active extracts of cells can
be employed for tolerance-induction, instead of
living cell suspensions, the risk of initiating
potentially harmful graft-versus-host reactions
is totally eliminated.
There is, in theory, a method of minimizing
the immunological problem to be overcome in
clinical homotransplantation, thereby greatly
facilitating its solution by the sort of treatments
outlined above. This entails being able to select
donors in such a way as to avoid major histo-
incompatibility situations. At present it seems
unduly optimistic to anticipate the discovery of
means of "typing" individuals with respect to
their histocompatibility antigens within the
near future. Even if this could be done, it's ex-
tremely unlikely that completely histocompatible
donors could be found for many patients needing
renal or other homografts—the number of iso-
antigenic combinatorial possibilities is almost
certainly much too great. Moreover, not everyone
would be prepared to accept the risks entailed in
giving up one of his kidneys for the sake of an
unknown recipient, even if it would be immuno-
logically acceptable.
As a useful interim measure, it should not be
too difficult to devise a satisfactory method for
selecting for a given patient, the most compatible
graft donor from a small panel of volunteers,
preferably drawn from his consanguineous rela-
tives. Considerable effort is being directed to-
wards this end (57). Especially encouraging re-
sults have been obtained by Brent and Medawar
(58) in experiments conducted in guinea pigs.
They have developed a simple cutaneous test
involving intradermal inoculation of potential
donors with suspensions of the recipient's small
lymphocytes. Essentially, this measures the
intensity with which the host's immunologically
competent cells can react against the transplanta-
tion antigens of the various possible donors.
Although outside the scope of this address, the
storage of tissues or organs for grafting purposes
still presents important unsolved problems,
though the principle that mammalian cells will
survive for several years at very low temperatures
has been firmly established for several tissues,
including skin, and for spermatozoa (59, 60).
Naturally one's thoughts go to the cadaver as
providing the ideal solution to the donor problem,
hut unfortunately attempts to use fresh cadaver
renal homografts have not given very encourag-
ing results. Furthermore, cadavers are likely to
prove difficult subjects for matching tests.
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Thymectomy and Abrogation of
Homograft Reactivity
One of the most recent discoveries in which
tissue transplantation has played a leading role
concerns the hitherto unknown functional sig-
nificance of the thymus (61). It was independently
reported, first by Miller and soon afterwards by
Martinez and Good, that thymectomy of new-
born mice results in a considerable impairment
of their ability to react against skin homografts,
and even against rat skin heterografts, in later life.
This effect, which is completely non-specific, and
extends to conventional antigens, as well as to
other species, including rats and hamsters, de-
pends upon the fact that early thymectomy
leads to a gross deficiency of functional lymphoid
tissue. Until recently, all the evidence pointed
to the thymus in pre- and early post-natal life
as the primary source of the progenitors of lym-
phocytes, apparently confirming a prediction
made by Beard (62) in 1899 on the basis of his-
tological studies on skate embryos.
However, Miller (63) has recently shown that
mice thymectomized at birth may attain normal
immunological reactivity if neonatal thymic
tissue, sequestered in cell-impermeable Millipore
chambers, is inserted in their peritoneal cavities.
This important observation hints that the thymus
exerts its influence on the development of the
lymphoid tissue system via a humoral agent
rather than by providing the primordial lymphoid
stem cell population.
There is recent evidence that even in adult life
the thymus may still play an important role in
the maintenance of the functional activity of the
machinery of immunological response.
The situation may be even more complex in
birds than in mammals, for in chickens there
may be two different seats of lymphoid cell
primordia (or lymphoid cell controlling factors):
—the thymus and the Bursa of Fabricius, a
diverticulum of the cloaca. Apparently the two
descendant, or "influenced", lymphoid cell
populations differ in their immunological func-
tion, the thymus being the source of the cells
responsible for homograft reactivity (64).
5. THE MAMMALIAN FETUS
QUA HOMOGRAFT
Every living mammal in a non-inbred popula-
tion may be said to represent a naturally suc-
cessful hornograft in the sense that it was once
"parabiotically" united to its mother, towards
which it was potentially antigenic in respect of
the transplantation antigens it inherited from its
father and which the mother lacked. This almost
consistent and anomalous success of fetuses as
homografts has long challenged the ingenuity of
transplantation immunologists who have put
forward various hypotheses to account for it
(22). Everyone was in agreement that the com-
plete separation of the maternal and fetal blood
circulations is the most important factor here,
preventing any appreciable exchange of cells.
However, one cannot escape the fact that mater-
nal and fetal tissues are in intimate contact.
Simmons and Russell (65) have recently shown
that the trophoblast, which constitutes an un-
interrupted boundary of fetal tissue in intimate
contact with maternal tissue, primarily blood,
consists of cells that either lack transplantation
antigens or fail to express them. Thus it seems to
provide a perfect immuno]ogical insulation,
being both incapable of provoking maternal
sensitization and insusceptible to an existing state
of sensitization.
6. TRANSPLANTATION IN RESEARCH ON SKIN
So far, little use has been made of skin trans-
plantation to study the etiology or principles
underlying diseases or abnormalities of the in-
tegument in man, or its untoward response on
exposure to contact allergens. The pioneer in this
area was Haxthausen (66), who in 1947 recipro-
cally exchanged autografts between areas of
normal and affected skin in cases of scleroderma,
vitiligo and acrodermatitis atrophicans. This
work indicated the predominant influence of
"local trophic influences" in these conditions.
In lentigo, by contrast, no such influence was
demonstrable. Long (67) has recently used this
approach to study psoriasis.
In a study of considerable importance to both
dermatologists and immunologists Haxthausen
ingeniously side-stepped the severe restriction
imposed by the homograft reaction, by employing
identical twins, which as Bauer (68) had shown
in 1927, will permanently accept grafts of each
others' skin, as genetical theory predicted. He
demonstrated (69) that skin transplanted from a
normal individual to his twin, previously sen-
sitized to a simple chemical allergen—dinitro-
chlorobenzene—gave a positive reaction on
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challenge with this allergen. However, skin from
a sensitized subject grafted onto his normal twin
did not respond when challenged with this agent,
indicating that delayed hypersensitivity to this
allergen is not tissue hound.
In another study this investigator showed that
the time restriction imposed by the homograft
reaction does not entirely exclude the judicious
use of orthotopic skin homografts for investigat-
ing delayed allergies in man (70). He found that
skin homografts from normal subjects can mani-
fest their new host's sensitivities as soon as they
have acquired a blood supply—ic., from about
the third day onwards.
Obviously, for a variety of purposes, it would
be extremely useful if small grafts of human skin
could be made to outlive their orthotopic trans-
plantation to a convenient experimental animal
for an experimentally worthwhile period. Un-
fortunately, since hetcrotran.s plantation (or Zoo-
grafting) is involved here, I feel very pessimistic
whether this will ever be a practical possibility.
All that can be done, at present, is to take ad-
vantage of the immunologically privileged site
afforded by the sub-epithelial connective tissue
of the Syrian hamster's cheek pouch (adminis-
tration of cortisone to the host helps to prolong
the lives of such grafts here), or the immunologi-
cal immaturity of newborn rats or chick embryos
(1, 51). The "dropped" chorioallantoic mem-
branes of 8—10 day old chick embryos will vas-
cularize and sustain a skin heterograft in a reason-
ably normal condition for about 9 days.
Many problems concerned with the biology of
skin can best be undertaken in experimental
animals, where, by the use of autografts, or
isografts exchanged between members of isogenic
strains, the investigator is enabled to free him-
self entirely of immunological obstacles. There
are several important problems of skin biology
where tissue transplantation has already played,
or may be expected to play, an indispensible
role :—a) In the elucidation of the embryological
origin of melanocytes, and the genetic control of
the functional activity of these cells (71, 72). By
appropriate experimental artifices, melanocytes
of one genetic constitution have been "intro-
duced" into follicles of another, enabling the
influence of the follicular milieu on the melano-
genie activity of the pigment cell to be studied.
b) In demonstrating that the phenomenon of
pigment spread in guinea pigs' skin (71), so far
as encroachment of black epidermal pigmentation
into white skin areas is concerned, is the result
of melanocyte migration from the pigmented
areas into the amelanotic areas (73). I feel op-
timistic that transplantation procedures may yet
prove decisive in resolving the question of the
relationship of the "cell of Langerhans" to the
melanocyte.
c) In the elucidation of the origin and con-
servation of regionally distinctive anatomical
variants of the cutaneous system (74). By study-
ing composite grafts, in which the isolated epi-
dermis of one type of skin has been re-associated
with the denuded papillary layer of the dermis of
another, it should be possible to settle, once and
for all: i) Whether there are intrinsic differences
between, say, the basal layer cells of the epidermis
of the general integument, and cells that con-
stitute the germinal matrix of the hair follicle, or
the onychogenic epithelium that produces our
finger nails, or ii) Whether the dermis in every
case furnishes the structural "code", or iii)
\%Thether the distinctive type of epidermis produced
results from dermo-epidermal exchanges and
interactions. This approach would supplement
existing studies of Sengel and others conducted
in eitro, using a similar principle.
d) In investigating the factors responsible for
the cyclical de novo formation of new skin, com-
plete with pilosebaceous units, in the "velvet"
which covers the growing antlers of deer (75, 76).
e) In elucidating the mechanism underlying
the passage of cyclical waves of hair growth
activity in a symmetrical manner over the in-
tegument of certain rodents (77).
It is interesting to note that one of the earliest
applications of grafting to study the pilary system
simply involved the excision of a free skin graft
from a mouse's trunk and its re-implantation in
the original donor site, with reversed orientation.
The regenerated hairs maintained their original
direction of slope, which is therefore an intrinsi-
cally determined attribute. This experiment was
carried out by Schone at the beginning of this
century (see 78).
7. TRANSPLANTATION AND AGEING
The ill-founded belief that testicular grafts
could ameliorate some of the adverse effects of
old age was fairly widespread at the beginning
of this century and there was certainly no short-
age of clinical reports to sustain it. Best known
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among the "testicular rejuvanists" was Voronoff,
who encouraged the belief that heterografts
from apes to men could succeed. Now, as we are
regretfully aware, this work (another form of
zoografting) has been thoroughly discredited. It
has been well established that even homografts
of endocrine tissues are, at best, only slightly
less exacting in their immunological requirements
for survival than skin (79, 1). It is just worth
mentioning that a few homologous or heterol-
ogous tissue cell therapists still flourish in Europe
(80), the inadequacy of the rationale of their
medication apparently being made good in most
cases by the faith and eminence of some of their
recent "victims".
Krohn (81) has recently shown that trans-
plantation affords an important analytic pro-
cedure in gerontology for revealing whether
certain organs of the body age according to
intrinsically determined programs, or according
to a centrally determined control system. This
procedure is applicable to tissues that can be
transplanted and to species in which trans-
plantation immunity can be circumvented. It
requires the production of age chimeras (or hetero-
chronic chimeras), bearing a functional organ or
tissue graft that is chronologically much older
or much younger than the host. Krohn's studies
on orthotopic ovarian transplants in inbred
strains of mice have shown that deficiencies in
this organ are not primarily responsible for the
discontinuation of its reproductive function,
though they can be the reason for cessation of
hormone production.
I'm sure all of us have contemplated the atroph-
ic, inelastic, inert-looking skin about the jowls
and other regions of some old gentlemen, and
wondered whether it could ever be persuaded to
regain its initial properties. Krohn addressed
himself to this sort of question in mice, studying
grafts of old skin placed upon young hosts, and
skin grafts maintained for very long periods by
serial propagation from one mouse to another.
His provisional conclusions are :—a) that al-
though skin maintained by grafting has a much
longer life span than a mouse, it does eventually
attain an age at which progressive degenerative
changes appear, such as contraction, loss of fur
and ultimate disintegration. Placement of such
degenerating skin upon a young host does not
result in its rejuvenation. It is as if the skin has a
finite life-span, however it is maintained. The
possibility that these degenerative changes may
be due to trauma, associated with repeated
grafting or other non-specific factors, cannot at
present be excluded. Experiments to evaluate
these possibilities are in progress.
8. TRANSPLANTATION IN EMBRYOLOGY
AND ENOOCRTNOLOGY
Two important subjects in which tissue trans-
plantation has played an indispensible role are
Experimental Embryology and Endocrinology.
In the former, grafting experiments have made
classic contributions to our understanding of
determination, self-differentiation and embryonic
induction (82, 83).
In endocrinology, transplantation furnishes
one of the important defining criteria of the
endocrine function of a tissue—it must be possible
to restore the effects of extirpation of a presumed
endocrine tissue by replacing it in the host in an
anatomically abnormal site. More recently
transplantation has become a standard technic
to elucidate a wide variety of endocrine mecha-
nisms and interrelationships (79).
John Hunter was certainly one of the pioneers
in endocrine tissue transplantation, since he
transplanted gonads in chickens in 1771. How-
ever, it was Berthold (84) who made the classical
demonstration of the endocrine function of a
gland—the testis—by extirpation and trans-
plantation in cockerels in 1849.
Although there was once a phase during which
transplantation of endocrine tissue was used as
a rather unsatisfactory form of therapy for cer-
tain hormonal deficiencies, this has long been
discontinued as extracted or synthetic hormones
have become available. However, if a relatively
simple procedure can be devised for overcoming
the homograft reaction, then we can confidently
anticipate a renewal of interest in the surgical
replacement of endocrine organs.
It is worth mentioning that fairly convincing
claims are still being made that transplantation
of homografts, or even heterografts, of para-
thyroid tissue sometimes has a lasting beneficial
influence in cases of hypoparathyroidism (85).
Survival of these grafts for more than a very
short time can certainly be discounted as a
contributory factor here.
9. CONCLUSIONS
From this rather cursory and by no means
complete survey of the highly diverse fields of
research activity encompassed by the term
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"transplantation", it is obvious that the one
which currently predominates, in terms of the
effort and interest it commands, is that con-
cerned with the immunology of transplantation.
What is the particular appeal of tissue trans-
plantation to an investigator? One's research
interests, like hobbies (to some extent these are
synonymous or should be) are highly individual
and usually difficult to rationalize or justify.
Unfortunately we sometimes have to do this
when applying for grants and fellowships and
immediately become aware that to tell the truth
might be dangerous. For pigment cell workers
the bizarre forms which melanocytes assume is
usually a never-ending source of attraction and
pleasure. As an experimental skin grafter, I
always derive an indefinable sense of satisfaction
from the sight of a well-healed graft of my own
execution, forgetting that Nature deserves most
of the credit. This satisfaction is heightened if
acceptance of the graft has been enforced upon a
potentially resistant host by an experimental
artifice. One looks at various problems of experi-
mental biology or medicine with a one-track
mind—can they be formulated in such a way
that they can be solved by some sort of grafting
procedure?
The generosity of my hosts on this very special
occasion is such that I shall make no attempt to
deceive them. I have always been a clandestine
subscriber to the principle of serendipity in
research (for the same reason, perhaps, I do not
disbelieve in the existence in ghosts) being pre-
pared to carry out an experiment if I felt that it
was worth doing, even if I couldn't rationalize it.
The proof of the pudding is always in the eating.
Many years ago I remember telling a distin-
guished authority of my intention to "see what
would happen if I injected a suspension of living,
homologous epidermal cells intravenously into
adult rabbits". The idea met with a rather cold
reception; my mentor reminded me that the
intravenous route in this species is a very ineffec-
tive one from the viewpoint of sensitization with
leucocytes. Undaunted, but clandestinely, I
went ahead. I found that the information I'd
been given was perfectly correct so far as it went.
Neither epidermal cells nor leukocytes injected
intravenously sensitized the rabbits in respect of
subsequent skin homografts. Indeed, in many
cases they did exactly the opposite, abrogating
the hosts' capacity to reject homografts to an
extent that doubled or even trebled their "life
expectancy" (48)—presumably as a consequence
of the induction of some form of transplantation
tolerance.
On another occasion I suggested that since all
domestic Syrian hamsters have originated from
three litter-mates captured in Syria in 1930, they
should have attained genetic uniformity by now,
through close consanguineous matings. Accep-
tance of exchanged skin grafts should therefore
be the rule rather than the exception. This time
I foolishly desisted from putting the matter to
the test when my genetic reasoning was quite
justifiably dismissed as unsound. Nevertheless,
it was later discovered independently by Adams
in Boston, and by Hildemann and me in London,
that hamsters are indeed anomalously hospitable
towards skin homografts (86, 87).
The moral of these anecdotes is obvious. It is
not always expedient to consult one's peers
about the merits of a projected experiment:
rather, seek their advice on interpretation of the
findings. However, if you follow your heart in
carrying out an experiment and it yields interest-
ing results, it may lead to some embarrasment
when you try and write the "Introduction" to
your paper. How many people really tell the
truth when describing what led them to under-
take a particular piece of research? Why did
John Hunter really graft the spur from a
cockerel's leg onto its comb? What led SchOne to
graft the entire dorsal integumentary skin from a
newborn mouse onto its mother's back (see 77)?
Certainly the results of these two experiments
were exceedingly interesting.
However, I do not wish to appear to be giving
irresponsible advice to would-be transplanters.
Research in transplantation requires some
apprenticeship. Woglom (18) wrote in 1929 that
". . . cancer research is a discipline requiring
some apprenticeship and not everyone with an
inoculating needle and a dozen white mice can
plunge in and make a discovery". A similar
caution is still justified in the light of many of
the abundant publications appearing under the
heading of transplantation immunology. For
example, many people are still rushing into skin
homograft work before they have studied the
literature, properly mastered the technics of
skin grafting, learned to avoid the pitfalls
afforded by "active" skin, etc., or how to ap-
praise the fate of their grafts properly.
I have been very lucky. I entered the trans-
plantation field in 1946, as a student of Dr.
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P. B. Medawar with whom I had the privilege
of collaborating for many years. At this time the
appearance of a new contribution in the litera-
ture was a rare event. Now the weekly yield of
literature on the subject makes the task of keep-
ing fully abreast of it quite formidable, if not
impossible. The "unexpected" has oecnrred
several times in my research career, each time
furnishing us with several years' enjoyable
"follow-up" work. Our attempts to use skin
grafting to distinguish monozygotie from dizy-
gotic cattle twins led us to the principle of im-
munological tolerance; our employment of adult
blood as a tolerance-conferring stimulus caused
'runt disease in many of our chick embryos. Al-
though we failed to appreciate the significance of
this condition at first, blaming hypothetical
parasites (88), Brent and I (35) were fortunate
to recognize it when it appeared later in the
course of experiments designed to induce toler-
ance by injection of newborn mice with
homologous splenic cells.
These are some of the considerations that have
made research in transplantation so pleasurable
for me and, I snspeet, for many others too. As
any branch of science progresses and becomes
knit together by a sound fabric of hypotheses and
theory the chances of revealing the unexpected
tend to diminish. It is my regretful opinion that
we have now passed the peak of the "Gold-
Rush" days of research in transplantation im-
munology. The principal fields and phenomena
seem to have been pretty well mapped out and
the basic principles revealed, at least in outline.
Perhaps the time has come for me to "revisit"
skin for its own sake and become an experimental
dermatologist again.
REFERENCES
1. BILaINOITAM, R. E. AND SILvERs, W. K., eds:
Transplantation of Tissues and Cells, 149
pp. Philadelphia, The Wistar Institute Press,
1961.
2. WOODRUFF, M. F. A.: The Transplantation of
Tissues and Organs, 777 pp. Springfield, Ill.
Charles C Thomas, 1960.
3. WoasmNrioasa, C. E. W. AND CAMERON, M.
P., eds: Preservation and Transplantation
of Normal Tissues, Ciba Foundation Sympo-
sium, 236 pp. London, J & A Churchill, 1954.
4. PEER, L. A., ed: Transplantation of Tissues,
Vol. 1, 421 pp. Baltimore, Williams and
Wilkins, 1955.
5. Past presidents of the college: 4. Sir Erasmus
Wilson. Ann. ROF. Coll. Surg. Eng., 10: 66,
1952.
6. RooREs, B. 0.: Transplantation of skin. In
Transplantation of Tissues, Vol. 2, 73 L. A.
Peer, ed. Baltimore, Williams and Wilkins,
1959.
7. Baorcio, C.: Degli Innesti Animali. Milan,
1804.
S. BUNGER, C.: Gelungener Versuch einer Nasea-
bildung aus einem vollig getrennten Haut-
stuck aus dem Beine. J. d. Chir. u. Augenh.,
Berlin, 4: 569, 1822.
9. REvERDIN, J. L.: Greffe épidermique. Expéri-
ence fait dans la service de M. le docteur
Guyon a l'hSpital Neeker. Bull. Soc. Chir.,
Paris, 2 Sér, 10: 511, 1870.
10. Giasox, T.: Zoografting: A curious chapter in
the history of plastic surgery. Brit. J. Plast.
Surg., 8:234, 1955.
11. Roons, B. 0., CONVERSE, J. M. AND SILvETTJ,
A. N.: Preliminary clinical studies on bovine
embryo skin grafts. Transplant Bull., 4: 24,
1957.
12. SILYETTI, A. N., COTTON, C., BYRNE, R. J.,
BERRIAN, J. H. AND MENENDEZ, A. F.: Pre-
liminary experimental studies of bovine
embryo skin grafts. Transplant Bull., 4: 25,
1957.
13. LAwsoN, G.: On the transplantation of por-
tions of skin for the closure of large granu-
lating surfaces. Trans. Clin. Soc. Lond., 4:
49, 1870.
14. MEDAwAR, P. B.: Notes on the problem of skin
homografts. Bull. War Med., London, 4:
1, 1943.
15. MEDAwAR, P. B.: The Immunology of Trans-
plantation. In The HarveF Lectures, 1956—
1957, 144, N. Y., Academic Press, 1958.
16. CHIJRCHILL, W. S.: My Early Life. London,
Collins, 1930.
17. WOGLOM, W. H.: Studies in cancer and allied
subjects. The study of experimental cancer.
A review. N. Y., Columbia University Press,
1913.
18. Wooaon, W. H.: Immunity to transplantable
tumor. Cancer Hey., 4: 129, 1929.
19. PRNIIN, H. T.: Tumor specific antigens and the
homograft reaction. Amer. J. Surg., 105: 184,
1963.
20. MEDAwAR, P. B.: The homograft reaction.
Proc. Roy. Soc., Lond., B, 149:145, 1958.
21. SCH0NE, C.: Vergleichende Untersuchungen
uber (lie Transplantation von Geschwulsten
und von normalen Geweben. Bruns. Beitr.
Khn. Chir., 61: 1, 1908.
22. BIaLINOHAM, H. E. AND SILvEas, W. K.:
Sensitivity to homografts of normal tissues
and cells. Ann. Rev. Microbiol., 17: in press.
1963.
23. CORER, P. A.: Some recent work on tumor im-
munity. Advances Cancer Res., 4: 149, 1956.
24. WINN, H. J.: The immune response and the
homograft reaction. Nat. Cancer Inst.
Monogr., No. 2., 113, 1960.
25. KALI55, N.: The elements of immunologic en-
hancement: A consideration of mechanisms.
Ann. N.Y. Acad. Sd., 101:64,1962.
26. MITCEI5ON, N. A.: Passive transfer of trans-
plantation immunity. Proc. Roy. Soc. Lond.,
B, 142:72,1954.
27. BILLINOHAM, R. E., SILvERs, W. K. AND
WILsoN, D. B.: Further studies on adoptive
transfer of sensitivity to skin homografts.
J. Exp. Med., in press. 1963.
28. HO5ENAU, W. AND Moox, H. D.: Lysis of
TRANSPLANTATION: PAST, PRESENT AND FUTURE 179
homologous cells by sensitized lymphocytesin tissue culture. J. Nat. Cancer Inst., 27:
4Z1, 1961.
29. BILLINGHAM, R. E., BRENT, L. AND MEDAWAR,P. B.: The antigenic stimulus in trans-
plantation immunity. Nature, (London),
178: 514, 1956.
30. OWEN, R. D.: Immunogenetic consequences of
vascular anastomoses between bovine twins.
Science, 102:400, 1945.
31. ANDERSON, D., BILLINGHAM, R. E., LAMPKIN,
G. H. AND MEDAWAR, P. B.: The use of skin
grafting to distinguish between monozygotic
and dizygotic twins in cattle. Heredity, 5:
379, 1951.
32. BILLINGHAM, R. E.: Acquired tolerance of
foreign cells. In Cellular Mechanisms in
Differentiation and Growth, 221, D. Rud-
nick, ed. Princeton, N. J., Princeton Univer-
sity Press, 1956.
33. BILLINGHAM, R. E.: Actively acquired toler-
ance and its role in development. In The
Chemical Basis of Development, 575. W. D.
McElroy and B. Glass eds., Baltimore, Md.,
Johns Hopkins Press, 1958.
34. MEDAWAR, P. B.: Immunological tolerance.
Science, 133: 303, 1961.
35. BILLINGHAM, R. E. AND BRENT, L.: Quantita-
tive studies on tissue transplantation im-
munity. IV. Induction of tolerance in new-
born mice and studies on the phenomenon of
runt disease. Phil. Trans. Lond. B., 242: 439,
1959.
36. MEDAWAR, P. B.: Theories of immunological
tolerance. In Cellular Aspects of Immunity,
Ciba Foundation Symposium, 149, G. E. W.
Wolstenholme and M. O'Connor, eds., Lon-
don, J & A Churchill, 1960.
37. BTJRNET, F. M.: The Clonal Selection Theory
of Acquired Immunity, 208 pp. Nashville,
Tenn., Vanderbilt University Press, 1959.
38. BILLINGHAM, R. E., DEFENDI, V., SILVERS, W.
K. AND STEINMULLER, D.: Quantitative
studies on the induction of tolerance of skin
homografts and on runt disease in neonatal
rats. J. Nat. Cancer Inst., 28: 365, 1962.
39. SIMONSEN, M.: Graft versus host reactions.
Their natural history, and applicability as
tools of research. Progress in Allergy, VI:
349. New York & Basel, S. Karger, 1962.
40. GOWANS, J. L., MCGREGOR, D. D. COWAN, D.
M. AND FORD, C. E.: Initiation of immune
responses by small lymphocytes. Nature,
196: 651, 1962.
41. TERASAKI, P.: Identification of the type of
blood cell responsible for the graft-versus-
host reaction in chicks. J. Embryol. Exp.
Morph., 7: 394, 1959.
42. BILLINGHAM, R. E. AND SILVERS, W. K.: The
immunological competence of chickens'
skin. J. Immun., 82: 448, 1959.
43. SATJERBRUCH, F. AND HEYDE, M.: Ueber Para-
biose künstlich vereinigte Warmbluter.
Munchen. Med. Wschr., 55: 153, 1908.
44. KOLLER, P. C., DAVIES, A. J. S. AND DOAK, S.
M.: Radiation chimeras. Advances Cancer
Res., Academjc Press, N. Y. 6: 181, 1961.
45. STASTNY, P. AND ZIFF, M.: Homologous dis-
ease in the adult rat: A model for autoim-
mune disease. Ann. N. Y. Acad. Sci., 99:
663, 1962.
46. RUSSELL, P. 5.: Modification of runt disease
in mice by various means. In Trans-
plantation, Ciba Foundation Symposium,350. G. E. W. Wolstenholme & M. P.
Cameron eds., London, Churchill, 1962.
47. G. A. AND KINSKY, R.: Protection
against runting by specific treatment of new-
born mice, followed by increased tolerance.
In Transplantation, Ciba Foundation Sym-
posium, 286, G. E. W. Wolstenholme & M.
P. Cameron eds., London, Churchill, 1962.
48. BILLINGHAM, R. E. AND SPARROW, E. M.: The
effect of prior intravenous injections of dis-
sociated epidermal cells and blood on the
survival of skin homografts in rabbits. J.
Embryol. Exp. Morph., 3: 265, 1955.
49. MERRILL, J. P., FRIEDMAN, E. A., WILSON, R.
E. AND MARSHALL, D. C.: The production
of "delayed type" cutaneous hypersensitiv-
ity to human donor leucocytes as a result of
the rejection of skin homografts. J. Clin.
Invest., 40: 631, 1961.
50. BILLINGHAM, R. E. AND BOSWELL, T.: Studies
on the problem of corneal homografts. ProC.
Roy. Soc., Lond., B, 141: 392, 1953.
51. BILLINGHAM, R. E. AND SILVERS, W. K.:
Studies on cheek pouch skin homografts in
the Syrian hamster. In Transplantation,
Ciba Foundation Symposium, 90, G. E. W.
Wolstenholme and M. P. Cameron, eds.,
London, Churchill, 1962.52. CRAIGMYLE, M. B. L.: A study of cartilage
homografts in rabbits sensitized by a skin
homograft from the cartilage donor. Trans-
plant Bull., 26: 150, 1960.
53. MURRAY, J. E., MERRILL, J. P., DAMMIN, G. J.,
DEALY, J. B., ALEXANDRE, G. W. AND
HARRISON, J. H.: Kidney transplantation in
modified recipients. Ann. Surg., 156: 337,
1962.
54. HAMBURGER, J., VAYSSE, J., CROSNIER, J.,
AUVERT, J., LALANNE, C. M. AND HOPPER,J.: Renal homotransplantation in man after
radiation of the recipient. Amer. J. Med.,
32: 854, 1962.
55. MURRAY, J. E., MERRILL, J. P., HARRISON, J.
H., WILSON, R. E. AND DAMMIN, G. J.: Pro-longed survival of human-kidney homo-
grafts by immunosuppressive drug therapy.
New Eng. J. Med., 268: 1315, 1963.
56. MEDAWAR, P. B.: The use of antigenic tissue
extracts to weaken the immunological reac-
tion against skin homografts in mice. Trans-
plantation, 1: 21, 1963.
57. MATSUKURA, M., MERY, A. M., AMIEL, J. L.
AND MATH, G.: Investigation on a test of
histocompatibility for allogeneic grafts. II.A study on rabbits. Transplantation, 1: 61,
1963.
58. BRENT, L.: AND MEDAWAR, P. B. personal
communication, 1963.
59. PARKES, A. S., Leader: A Discussion on Vi-
ability of Mammalian Cells and Tissues after
Freezing. Proc. Roy. Soc., Lond., B, 147:
423, 1957.
60. Symposium on Preservation of Cells. Fed.
Proc., 22: 80, 1963.
61. MILLER, J. F. A. P., MARSHALL, A. H. E. AND
WHITE, R. G.: The immunological influence
of the thymus. In Advances in Immunology,
2: 111, W. H. Taliaferro & J. H. Humphrey,
eds. N. Y., Academic Press, 1961.
180 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
62. BEARD, J.: The true function of the thymus.
Lancet, 1: 144, 1899.
63. MILLER, J. F. A. P.: The role of the thymus in
the origin of lmmunologieal competence,
Ciba Foundation Study Group—The Nature
and Origin of the Immunologically Com-
petent Cell. London, Churchill, 1963. in
press.
64. WARNER, N. L., SZENBERO, A. AND BURNET,
F. M.: The immunological role of different
lymphoid organs in the chicken. Aust. J.
Exp. Biol. Med., 49: 373, 1962.
65. SIMMONS, R. L. AND RUSSELL, P. S.: The
antigenicity of mouse trophoblast. Ann. N.
Y. Acad. Sci., 99: 717, 1962.
66. HAXTIIAUSEN, H.: Studies on the pathogene-
sis of morphea, vitiligo, and aerodermatitis
atrophicans by means of transplantation
experiments. Acta Dermatovener. (Stock-
holm), 27: 352, 1947.
67. LONG, P. I.: Behavior of psoriatie and normal
skin transplants. Arch. Derm. (Chicago),
84: 593, 1961.
68. BADER, K. H.: Homoiotransplantation von
Epidermis bei eineiigen Zwillingen. Beitr.
Khn. Chir., 141: 442, 1927.
69. HAXTRAUSEN, H.: The pathogenesis of
allergic eczema elucidated by transplanta-
tion experiments on identical twins. Acta
Dermatovener. (Stockholm), 31: 42, 1943.
70. HAXTHAUSEN, H.: The pathogenesis of aller-
gic eczema illustrated by transplantation
experiments. Aeta Dermatovener. (Stock-
holm), 31: 42, 1951.
71. BILLINGIJAM, R. E. AND SILVERS, W. K.: The
melanocytes of mammals. Quart. Rev. Biol.,
35: 1, 1960.
72. SILVERS, W. K.: Genes and the pigment cells
of mammals. Science, 134: 368, 1961.
73. BILLINGRAM, R. E. AND SILVERS, W. K.: Fur-
ther studies on the phenomenon of pigment
spread in guinea pigs' skin. Ann. N. Y. Aead.
Sci., 100: 348, 1962.
74. BILLINOHAM, H. E. AND SILVEES, W. K.: The
origIn and conservation of epidermal spec-
ifleities. New Eng. J. Med., 268: 477, 539,
1963.
75. BILLINGHAM, R. E., MANGOLD, R. AND
SILVERS, W. K.: The neogenesis of skin in
the antlers of deer. Ann. N. Y. Acad. Sci.,
83: 491, 1959.
76. GosS, R.: The role of skin in antler regenera-
tion. lID Advances in Biology of Skin. W.
Montagna and R. E. Billingham, eds., Ox-
ford, London; New York, Paris Pergamon
Press, 1964 in press.
77. MONTAONA, W.: The Structure and Function
of Skin, 2nd edition, 454 pp., N. Y., Academic
Press, 1962.
78. NEUHOF, H.: The Transplantation of Tissues,
297 pp. New York D. Appleton & Co., 1921.
79. KEOJIN, P. L.: Transplantation of endocrine
glands. Chapt. 12. In Transplantation of
Tissues, 2: 401. L. A. Peer, ed. Baltimore,
Williams and Wilkins, 1959.
80. ROGERS, B. 0.: What is "tissue therapy"?
Transplant Bull., 4: 47, 1957.
81. KEOHN, P. L.: Review lectures on Senescence.
II. Heteroehronic transplantation in the
study of ageing. Proc. Roy. Soc., London, B,
157: 128, 1962.
82. WEISS, P.: The Principles of DeVelopment:
A Test in Experimental Embryology, 601
pp. New York, Holt and Co. 1939.
83. WADDINGTON, C. H.: Principles of Embryol-
ogy, 510 pp. London, Allen and Unwin,
Ltd. 1956.
84. BEETROLD, A. A.: Transplantation der Hoden.
Arch. Anat. Physiol. u. wiss. Med., 16: 42,
1849.
85. JACoB, S. W. AND DUNPNV, J. E.: "Success-
ful" parathyroid transplantation. Amer. J.
Surg., 105: 196, 1963.
86. BILLINGNAM, H. E. AND HILDEMANN, W. H.:
Studies on the immunological responses of
hamsters to skin homografts. Proc. Roy.
Soc., London, B, 148: 216, 1958.
87. BILLINGRAM, R. E. AND SILVERS, W. K.: Skin
transplants and the hamster. Sci. Amer.,
208: 118, 1963.
88. BILLINGHAM, H. E., BRENT, L. AND MEOAWAE,
P. B.: Quantitative studies on tissue trans-
plantatioD immunity. III. Actively acquired
tolerance. Phil. Trans. Hoy. Soc., London,
239: 357, 1956.
89. M0LLI50N, P. L.: Blood group antibodies and
red cell destruction. Brit. Med. J., ii: 1035,
1959.
